PR NEWSWIRE

Previous Stories

Panduit Announces Acquisition of Subsea Cable and Pipe Protection Product Portfolio from DongWon EN-Tec Co., Ltd.

Jan 12 2023 - PR NewsWire

Expands Portfolio for Offshore Alternative Energy & Optical Communications Customers in Asia-Pacific Region MELBOURNE, Australia and TINLEY PARK, Ill., Jan….


With a Powerful Combination to Further Explore Its Field in New Energy Technology, Chery Joins Hands with CATL to Seek a New Chapter

Jan 12 2023 - PR NewsWire

CANBERRA, Australia, Jan. 11, 2023 /PRNewswire/ — Recently, Chery Group signed a strategic cooperation framework agreement with Contemporary Amperex Technology…


Teamworks Acquires Smartabase to Support the Digital Transformation of Human Performance Optimisation

Jan 12 2023 - PR NewsWire

Smartabase is a global leader in human performance optimisation software for elite sports and military organisations BRISBANE, Australia, Jan. 12,…


Kia extends Australian Open partnership to 2028

Jan 10 2023 - PR NewsWire

Kia to extend its support of the Australian Open as Major Partner to 2028 130 Kia vehicles to provide safe…


The University of Technology Sydney (UTS) launches international campaign inspiring learners to seize the opportunities of Industry 5.0

Jan 10 2023 - PR NewsWire

UTS’s latest campaign is inspiring lifelong learners to create a more human-centric, sustainable and resilient world as they enter the…


DroneShield Announces A Second $11 million Sale, Strong Momentum into 2023

Jan 10 2023 - PR NewsWire

SYDNEY, Jan. 10, 2023 /PRNewswire/ — DroneShield Ltd (ASX:DRO) (DroneShield or the Company) is pleased to advise a second record…


Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in the United States for the Treatment of Individuals with Multiple System Atrophy

Jan 10 2023 - PR NewsWire

U.S. now open for enrollment of rare, rapidly progressive Parkinsonian Disorder MELBOURNE, Australia and SAN FRANCISCO, Jan. 9, 2023 /PRNewswire/ – Alterity…


Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update

Jan 09 2023 - PR NewsWire

MELBOURNE, Australia, Jan. 9, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises it is presenting at…


Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation)

Jan 06 2023 - PR NewsWire

MELBOURNE, Australia and SAN FRANCISCO, Jan. 6, 2023 /PRNewswire/ — Alterity Therapeutics Limited ("Alterity" or the "Company") (ASX:ATH, NASDAQ:ATHE), a…


Nintex Appoints Jen Bailin As Its New Chief Commercial Officer

Jan 06 2023 - PR NewsWire

Company appoints industry exec to lead Sales and Marketing for the Nintex Process Platform MELBOURNE, Australia, Jan. 6, 2023 /PRNewswire/…


Analyse The Market From A Different Angle